Design Therapeutics, Inc. Depreciation
Design Therapeutics, Inc. (DSGN) reported Depreciation of $308.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-03
- Design Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $151.00K, a 0.66% decline year-over-year.
- Design Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $157.00K, a 1.26% decline year-over-year.
- Design Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $156.00K, a 4.70% increase year-over-year.
- Design Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $155.00K, a 1.31% increase year-over-year.
- Design Therapeutics, Inc. depreciation for fiscal 2025 was $622.00K, a 4.36% increase from fiscal 2024.
- Design Therapeutics, Inc. depreciation for fiscal 2024 was $596.00K, a 10.99% increase from fiscal 2023.
- Design Therapeutics, Inc. depreciation for fiscal 2023 was $537.00K, a 32.27% increase from fiscal 2022.
- Design Therapeutics, Inc. depreciation for fiscal 2022 was $406.00K, a 214.73% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $308.00K 10-Q · filed 2026-08-03 | $464.00K derived: sum of 3 quarters · filed 2026-08-03 | $619.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $157.00K 10-Q · filed 2026-04-28 | $313.00K derived: sum of 2 quarters · filed 2026-04-28 | $468.00K derived: sum of 3 quarters · filed 2026-04-28 | $620.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $311.00K derived: sum of 2 quarters · filed 2026-03-09 | $463.00K derived: sum of 3 quarters · filed 2026-08-03 | $622.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $307.00K derived: sum of 2 quarters · filed 2026-08-03 | $466.00K 10-Q · filed 2025-11-05 | $615.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $311.00K 10-Q · filed 2026-08-03 | $460.00K derived: sum of 3 quarters · filed 2026-08-03 | $613.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $159.00K 10-Q · filed 2026-04-28 | $308.00K derived: sum of 2 quarters · filed 2026-04-28 | $461.00K derived: sum of 3 quarters · filed 2026-04-28 | $612.00K derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $302.00K derived: sum of 2 quarters · filed 2026-03-09 | $453.00K derived: sum of 3 quarters · filed 2026-03-09 | $596.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $304.00K derived: sum of 2 quarters · filed 2025-11-05 | $447.00K 10-Q · filed 2025-11-05 | $585.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $294.00K 10-Q · filed 2025-08-07 | $432.00K derived: sum of 3 quarters · filed 2025-08-07 | $569.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $143.00K 10-Q · filed 2025-05-07 | $281.00K derived: sum of 2 quarters · filed 2025-05-07 | $418.00K derived: sum of 3 quarters · filed 2025-05-07 | $551.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $275.00K derived: sum of 2 quarters · filed 2025-03-10 | $408.00K derived: sum of 3 quarters · filed 2025-03-10 | $537.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $270.00K derived: sum of 2 quarters · filed 2024-11-07 | $399.00K 10-Q · filed 2024-11-07 | $523.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $262.00K 10-Q · filed 2024-08-05 | $386.00K derived: sum of 3 quarters · filed 2024-08-05 | $494.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $129.00K 10-Q · filed 2024-05-08 | $253.00K derived: sum of 2 quarters · filed 2024-05-08 | $361.00K derived: sum of 3 quarters · filed 2024-05-08 | $453.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $232.00K derived: sum of 2 quarters · filed 2024-03-19 | $324.00K derived: sum of 3 quarters · filed 2024-03-19 | $406.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $200.00K derived: sum of 2 quarters · filed 2023-11-13 | $282.00K 10-Q · filed 2023-11-13 | $364.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $174.00K 10-Q · filed 2023-08-14 | $256.00K derived: sum of 3 quarters · filed 2023-08-14 | $287.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $82.00K 10-Q · filed 2023-05-09 | $164.00K derived: sum of 2 quarters · filed 2023-05-09 | $195.00K derived: sum of 3 quarters · filed 2023-05-09 | $207.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $113.00K derived: sum of 2 quarters · filed 2023-03-14 | $125.00K derived: sum of 3 quarters · filed 2023-03-14 | $129.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $43.00K derived: sum of 2 quarters · filed 2022-11-03 | $47.00K 10-Q · filed 2022-11-03 | $51.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $16.00K 10-Q · filed 2022-08-08 | $20.00K derived: sum of 3 quarters · filed 2022-08-08 | |
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-09 | $8.00K derived: sum of 2 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $5.00K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |